Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial

Eur Heart J. 2010 Jan;31(2):211-21. doi: 10.1093/eurheartj/ehp425. Epub 2009 Oct 23.

Abstract

Aims: To determine whether predictors of sudden cardiac death (SCD) vary with time after myocardial infarction (MI).

Methods and results: We analysed 11 256 patients enrolled in VALIANT. Landmark analysis and Cox proportional hazards modelling were used to predict SCD during hospitalization, from discharge to 30 days, 30 days to 6 months, and 6 months to 3 years. The cumulative incidence of SCD was 8.6% (n = 965). Initially, higher baseline heart rate [HR 1.20 per 10 b.p.m. (95% CI 1.06-1.37)] and impaired baseline creatinine clearance [HR 0.82 per 10 mL/min (95% CI 0.74-0.91)] were stronger predictors of SCD. With long-term follow-up, prior MI [HR 1.71 (95% CI 1.39-2.10)], initial left ventricular ejection fraction <40% [HR 0.67 per 10% (95% CI 0.58-0.78)], and recurrent cardiovascular events [HR 1.47 for rehospitalization (95% CI 1.17-1.86)] were more robust risk stratifiers for SCD. Atrial fibrillation post-MI was associated with an increased risk of SCD over the entire follow-up period. As time passed, the associations between baseline clinical characteristics and SCD decreased and time-updated assessments became more important.

Conclusion: Predictors of SCD change with time after MI. Future studies of risk stratification for SCD should account for changes in these factors with time after MI.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Captopril / therapeutic use
  • Death, Sudden, Cardiac / etiology*
  • Double-Blind Method
  • Female
  • Hospitalization
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / physiopathology
  • Proportional Hazards Models
  • Recurrence
  • Risk Factors
  • Stroke Volume / physiology
  • Tetrazoles / therapeutic use
  • Time Factors
  • Valine / analogs & derivatives
  • Valine / therapeutic use
  • Valsartan
  • Ventricular Dysfunction, Left / etiology

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Tetrazoles
  • Valsartan
  • Captopril
  • Valine